Treatment of a mutant KRAS lung cancer cell line with polyisoprenylated cysteinyl amide inhibitors activates the MAPK pathway, inhibits cell migration and induces apoptosisMatthew D. Gregory, Nazarius S. Lamango|PLoS ONE|2024Cited by 5